Precious Cells Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Precious Cells General Information

Description

Developer of stem cell technologies designed to increase the accessibility and scalability of stem cells to address the substantial stem cells gap worldwide. The company's service provides collecting, storing and supplying stem cells facility to those who need them, enabling customer in saving lives, improving health and changing medicine.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • Gardiner Building
  • Brunel Science Park
  • London UB8 3PQ
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Precious Cells Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 00.000 Completed Out of Business
1. Seed Round 24-May-2017 00.000 00.000 000.00 Completed Generating Revenue
To view Precious Cells’s complete valuation and funding history, request access »

Precious Cells Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 1 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Precious Cells’s complete cap table history, request access »

Precious Cells Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 30-Jul-2014 000000000000000000 Biotechnology 000000 00000
To view Precious Cells’s complete acquisitions history, request access »